Vivaldis Atopivet Oral Suspension for Dogs & Cats | Sphingolipids & Hyaluronic Acid | Atopic Dermatitis, Skin Barrier Restoration, Pruritus & Chronic Skin Allergy Management

For veterinary use. Administer as directed by a licensed veterinarian. Keep out of reach of children. Store in a cool, dry place away from direct sunlight. Shake well before use. Atopic dermatitis and chronic allergic skin disease in dogs and cats require full veterinary diagnosis and management — this oral suspension provides nutritional and skin barrier supportive supplementation and is not a substitute for veterinary diagnosis or prescribed dermatological treatment.

Vivaldis Atopivet Oral Suspension for Dogs & Cats (60ml | 120ml)

Vivaldis Atopivet is a veterinary oral suspension formulated to support skin barrier function, reduce pruritus (itching), and manage chronic skin inflammation in dogs and cats with atopic dermatitis, skin allergies, and allergic skin disease. Key active ingredients include sphingolipids and hyaluronic acid, targeting epidermal lipid barrier restoration and dermal hydration. For daily oral administration as part of a veterinary-managed atopic dermatitis and skin allergy treatment programme. Confirm complete active ingredient composition, concentrations per ml, and any additional actives (e.g. quercetin, palmitoylethanolamide/PEA, borage oil, or other) from the Vivaldis Atopivet product label or package insert.

Composition (confirm from product label)

• Sphingolipids — confirm mg per ml from label: Bioactive lipid molecules that are structural components of the skin's stratum corneum (epidermal lipid barrier); ceramides are the primary sphingolipid class in skin; ceramide deficiency in the stratum corneum is a well-established hallmark of atopic dermatitis in dogs and cats, leading to increased transepidermal water loss (TEWL), impaired barrier function, and enhanced allergen and microorganism penetration; oral sphingolipid supplementation supports restoration of ceramide-depleted stratum corneum and improvement of epidermal barrier integrity, reducing TEWL, sensitivity to environmental allergens, and secondary microbial colonisation risk; confirm sphingolipid source, ceramide class, and concentration per ml from Vivaldis Atopivet product label
• Hyaluronic Acid (Sodium Hyaluronate) — confirm mg per ml from label: High-molecular-weight glycosaminoglycan naturally present in the dermis and extracellular matrix; potent humectant with exceptional water-binding capacity (binds up to 1,000× its weight in water); oral hyaluronic acid supplementation supports dermal hydration, skin elasticity, and wound healing; may reduce dryness and improve skin moisture retention in pets with atopic dermatitis and dry skin conditions; confirm molecular weight and concentration per ml from label
• Additional active ingredients — confirm from Vivaldis Atopivet product label (may include Quercetin, Palmitoylethanolamide/PEA, Borage oil/GLA, or other anti-inflammatory and skin barrier-supportive actives)
• Oral suspension base and excipients — confirm from label

Therapeutic Class

• Veterinary oral dermatological nutritional supplement — skin barrier restoration, atopic dermatitis supportive management, pruritus reduction, and skin hydration for dogs and cats

Key Benefits

• Skin barrier restoration — sphingolipid/ceramide actives replenish ceramide-depleted stratum corneum, restoring epidermal lipid barrier integrity and reducing transepidermal water loss (TEWL) — the primary pathophysiological defect in canine and feline atopic dermatitis
• Pruritus (itch) reduction — improved skin barrier function reduces allergen, irritant, and microbial penetration into the epidermis, decreasing skin immune sensitisation and pruritic signalling; adjunctive anti-inflammatory actives (if present) directly reduce inflammatory mediator production and itch signalling
• Skin hydration and moisture retention — hyaluronic acid supports dermal water retention and skin elasticity, reducing dryness, flakiness, and skin fragility associated with chronic atopic dermatitis
• Chronic skin allergy management — daily oral supplementation supports long-term skin barrier maintenance as an adjunct to veterinary-prescribed antipruritic and immunomodulatory treatments (e.g. oclacitinib/Apoquel, lokivetmab/Cytopoint, allergen-specific immunotherapy)
• Reduced secondary infection risk — improved skin barrier function reduces transcutaneous penetration of environmental bacteria (Staphylococcus pseudintermedius) and Malassezia yeast, common secondary pathogens in atopic dermatitis flares

Indications

• Canine atopic dermatitis (CAD) — supplementary skin barrier support alongside veterinary diagnosis and management
• Feline atopic skin syndrome (FASS) — supplementary skin barrier and pruritus support
• Allergic skin disease and environmental allergen hypersensitivity in dogs and cats
• Chronic pruritus, skin inflammation, and recurrent skin flares associated with atopic disease
• Dry skin, reduced skin hydration, and impaired skin barrier function in dogs and cats
• Long-term skin care management as an adjunct to veterinary dermatological treatment

Pack Sizes

• 60ml: ₹1,698.00
• 120ml: ₹2,950.00

Directions for Use

• Shake well before use
• Administer orally as directed by a licensed veterinarian
• Dosage varies by body weight and species — confirm weight-based dose and dosing interval from the Vivaldis Atopivet product label or package insert
• Can be administered directly or mixed into food
• For best results, use as part of a consistent daily skin care programme under veterinary guidance; skin barrier restoration typically requires several weeks of consistent supplementation before full benefit is visible

Safety Information

• For veterinary use — administer under veterinary guidance
• Atopic dermatitis is a complex, lifelong allergic skin disease; a full dermatological workup (intradermal allergy testing, serology, food elimination trial) is recommended to identify underlying triggers and design a comprehensive management plan
• This oral suspension is a nutritional supplement supporting skin barrier function; it does not replace veterinary-prescribed antipruritic or immunomodulatory treatments where these are indicated
• Confirm suitability for pregnant, lactating, and breeding animals from product label or veterinarian before use
• Discontinue if any adverse reaction (gastrointestinal upset, vomiting, diarrhoea) is observed; consult a veterinarian
• Keep out of reach of children; store in a cool, dry place away from direct sunlight; keep cap tightly closed after use